PALATINI, PIETRO
 Distribuzione geografica
Continente #
NA - Nord America 6.225
AS - Asia 654
EU - Europa 598
SA - Sud America 11
OC - Oceania 5
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.495
Nazione #
US - Stati Uniti d'America 6.221
CN - Cina 323
SG - Singapore 243
FI - Finlandia 136
DE - Germania 116
IT - Italia 82
UA - Ucraina 81
SE - Svezia 62
GB - Regno Unito 57
VN - Vietnam 52
FR - Francia 43
PK - Pakistan 19
IN - India 12
IE - Irlanda 10
CL - Cile 6
NL - Olanda 4
HK - Hong Kong 3
MX - Messico 3
NZ - Nuova Zelanda 3
AU - Australia 2
BE - Belgio 2
BR - Brasile 2
PL - Polonia 2
RU - Federazione Russa 2
AR - Argentina 1
BD - Bangladesh 1
BO - Bolivia 1
CA - Canada 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
UZ - Uzbekistan 1
Totale 7.495
Città #
Fairfield 881
Woodbridge 776
Ann Arbor 648
Houston 551
Chandler 482
Jacksonville 374
Ashburn 328
Wilmington 304
Seattle 283
Cambridge 275
Singapore 187
Princeton 157
Santa Clara 157
Boardman 137
San Diego 88
Roxbury 83
Beijing 68
Nanjing 64
Medford 54
Dong Ket 52
Padova 49
Helsinki 40
Des Moines 39
Shenyang 30
Nanchang 23
Tianjin 20
Hebei 17
Norwalk 16
Jinan 15
Guangzhou 14
New York 14
London 11
Dublin 10
Changsha 9
Rawalpindi 9
Redwood City 9
Saarbrücken 9
Indiana 7
Kilburn 7
Sahiwal 7
Detroit 6
Falls Church 6
Jiaxing 6
Kharkiv 6
Chicago 5
San Francisco 5
Trier 5
Hefei 4
Munich 4
Tappahannock 4
Borås 3
Hong Kong 3
Ningbo 3
Ogden 3
Piove Di Sacco 3
Pune 3
Washington 3
Hangzhou 2
Hounslow 2
Lahore 2
Mexico City 2
Nürnberg 2
Opera 2
Perth 2
Pinehaven 2
Radomsko 2
Rockville 2
Shanghai 2
Taizhou 2
Treviso 2
Venice 2
Acton 1
Alghero 1
Arcos 1
Auburn Hills 1
Auckland 1
Bristol 1
Buffalo 1
Cairo 1
Castelfranco Veneto 1
Chiswick 1
Costa Mesa 1
Delhi 1
Duncan 1
Faisalabad 1
Falkenstein 1
Görwihl 1
Haikou 1
Islington 1
Kunming 1
La Canada Flintridge 1
Leawood 1
Livorno 1
Los Angeles 1
Milan 1
Monmouth Junction 1
Nashville 1
Neiva 1
New Bedfont 1
Pignone 1
Totale 6.433
Nome #
Biological and pharmacological properties of phospholipids. 170
In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: A comparison with human liver microsomes 145
Severe Liver Cirrhosis Markedly Reduces AhR-Mediated Induction of Cytochrome P450 in Rats by Decreasing the Transcription of Target Genes 141
Coadministration of sirolimus alters tacrolimus pharmacokinetics. 136
A comparison between different methods for the determination of reduced and oxidized glutathione in mammalian tissues 135
Effect of age on single- and multiple-dose pharmacokinetics of erythromycin 127
Penetration of carumonam into the pleural fluid: comparison of intravenous bolus and constant infusion in rats with experimentally induced pleurisy. 120
Effect of herpes simplex virus type 1 infection on nucleoside transport in HeLa S3 cells 120
Enzyme inhibition and induction in liver disease. 116
Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes 116
Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro. 114
Pharmacokinetic characterization of phosphatidylserine liposomes in the rat 112
Expression and distribution of the adrenomedullin system in newborn human thymus. 110
Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis 108
An intracellular adrenomedullin system reduces IL-6 release via a NF-kB-mediated, cAMP-independent transcriptional mechanism in rat thymic epithelial cells 106
Effects of single dose of gamma-hydroxybutyric acid and lorazepam in psychomotor performance and subjective feelings in healthy volunteers 105
A reassessment of the optimal sampling time for the MEGX liver function test 102
Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function 102
The effect of liver disease on inhibitory and plasma protein-binding displacement interaction:an update. 99
Pharmacokinetic drug interactions in liver disease: An update 99
Synergism between lysophosphatidylserine and the phorbol ester tetradecanoylphorbolacetate in rat mast cells. 95
The effect of age on plasma MEGX concentrations. 95
Canrenone as a partial agonist at the digitalis receptor site of (Na+-K+)ATPase 94
Inhibition of cytochrome P450 2C8-mediated drug metabolism by the flavonoid diosmetin. 94
Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosis 93
Further purification and characterization of the succinyl-CoA:3-hydroxy-3-methylglutarate coenzyme A transferase from rat-liver mitochondria. 93
Disposition kinetics of phospholipid liposomes. 93
Pharmacokinetics of intraperitoneal cisplatin and doxorubicin 92
Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis 91
Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients 90
Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity 90
Role of antioxidant defences in the species-specific response of isolated atria to menadione 89
Differential effect of liver cirrhosis on the pregnane X receptor-mediated induction of CYP3A1 and 3A2 in the rat. 87
Protective action of cardiac DT-diaphorase against menadione toxicity in guinea pig isolated atria 86
Neoral versus Sandimmun in kidney-pancreas transplantation. 86
Reactivation of a phospholipid-depleted sodium, potassium-stimulated ATPase. 86
Mechanism of Na+/K(+)-ATPase activation by trypsin and kallikrein. 86
Nephrotoxic effect of atractyloside in rats. 86
Influence of the mode of intravenous administration on the penetration of ceftazidime into tissues and pleural exudate of rats. 85
Mechanism of local anesthetic effect. Involvement of F0 in the inhibition of mitochondrial ATP synthase by phenothiazines. 84
Effect of gender on the monoethylglycinexylidide test in healthy subjects and patients with liver cirrhosis 83
The role of residual phospholipids and copurified proteins in the reconstitution of bovine heart mitochondrial ATPase complex. 83
A COMPARATIVE-ANALYSIS OF THE URINARY-EXCRETION PROFILES OF MESNA AND ARGIMESNA FOLLOWING ORAL-ADMINISTRATION TO HEALTHY-VOLUNTEERS 83
EFFECTS OF HERPES-SIMPLEX VIRUS TYPE-1 INFECTION ON THE PLASMA- MEMBRANE AND RELATED FUNCTIONS OF HELA S3 CELLS 82
Irreversible CYP3A Inhibition Accompained by Plasma Protein-Binding Displacement: A Comparative Analysis in Subjects with normal and impaired liver function. 82
Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. 81
The interaction of tricyclic antipsychotics with (Na+-K+)ATPase 81
Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosis. 80
The pharmacokinetics of teniloxazine in healthy subjects and patients with liver cirrhosis 79
Apomorphine-induced inhibition of histamine release in rat peritoneal mast cells. 78
Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis - Phase I study 78
Absorption and disposition kinetics of flunoxaprofen and benoxaprofen in healthy volunteers. 77
Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure 77
Liver dysfunction markedly decreases the inhibition of CYP1A2-mediated theophylline metabolism by fluvoxamine 77
Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. 76
F1-ATPase from different submitochondrial particles. 76
Effects of chronic renal failure and hemodialysis on the monoethylglycinexylidide liver function test. 75
Role of phosphatidylserine and phosphatidylcholine in the dicyclohexylcarbodiimide-induced inhibition of mitochondrial ATPase. 73
Needle and trocar injuries in diagnostic laparoscopy under local anesthesia: what is the true incidence of these complications? 71
Effect of renal flailure on metabolic disposition of lidocaine in patients undergoing and not undergoing hemodialysis 69
Mechanism of inhibition of sodium- and potassium-dependent adenosine triphosphatase by tricyclic antipsychotics 68
Liver dysfunction markedly decreases the inhibition of cytochrome P450IA2-mediated theophylline metabolism by fluvoxamine 68
Reversal by phospholipids of the oligomycin induced inhibition of membrane associated adenosintriphosphatases. 66
Inhibition of protein kinase activity by apomorphine. 66
Renal clearance of N-1-Methylnicotinamide is a marker of liver dysfunction in cirrhosis 65
Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. 64
Differential inducing effect of benzo[a]pyrene on gene expression and enzyme activity of cytochromes P450 1A1 and 1A2 in Sprague-Dawley and Wistar rats. 63
Anion activation of dopamine beta-hydroxylase: a kinetic model. 62
[Function of phospholipids in a membranous in a membranous complex with ATPase activity]. 61
Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase. 61
A new plot for multiple enzyme inhibition 61
Pharmacokinetics of miocamycin in patients with liver cirrhosis. 60
Evaluation ciprofloxacin and ofloxacin pharmacokinetics in liver cirrhosis. 60
Enzyme induction is independent on liver functional status 59
Mechanism of local anesthetic effect on mitochondrial ATP synthase as deduced from photolabelling and inhibition studies with phenothiazine derivatives. 54
The interaction between full and partial inhibitors acting on a single enzyme: a theoretical analysis 52
In vitro inhibition of cytochrome P450 (CYP) 2C8-mediated drug metabolism by the flavonoid diosmetin 51
Interazioni farmacocinetiche tra Tacrolimus e Sirolimus nel Trapianto Renale 50
Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis 48
Pharmacokinetic interactions between Tacrolimus and Sirolimus in Kidney Transplant recipients 48
Fumarate is the cause of the apparent ping-pong kinetics of dopamine beta-hydroxylase. 47
Effect of experimentally induced liver cirrhosis on CYP3A induction in male Wistar rats 43
Differential effect of liver dysfunction on CYP3A1 and CYP3A2 expression in rats with carbon tetrachloride-induced cirrhosis 43
Stereospecific disposition of flunoxaprofen enantiomers in human beings. 41
Mg-dependent inhibition of beef heart soluble mitochondrial ATPase by tricyclic antipsychotics 41
ORAL DISPOSITION KINETICS OF N-(AMINOSULPHONYL)-3-(((DIAMINOETHYLENE) AMINO)-N-THIAZOLYL) METHYLTHIOPROPANIMIDAMIDE (FAMOTIDINE) IN PATIENTS WITH LIVER-CIRRHOSIS 40
Effect of CYP 3A4 inhibition on lidocaine kinetics and the MEGS liver function test 39
Famotidine pharmacokinetics in the elderly: results of a preliminary study 39
Effect of liver functional status on the pharmacokinetic interaction between the CYP 1A2 inhibitor fluvoxamine and lidocaine 37
Inhibition of dopamine beta-hydroxylase by captopril. 37
A simple method for discriminating between full and partial inhibitors 35
Pharmacokinetics of gamma hydroxybutyric acid. 35
Inhibition of enzymes and enzyme by phenothiazines and their radicals. In: Phenothiazienes and 1,4-benzothiazines 32
Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid 31
Serine phospholipids as endocoids. 26
The behaviour of miocamycin kinetics in cirrhotic patients after single and repeated oral administration. 21
Totale 7.513
Categoria #
all - tutte 25.664
article - articoli 23.882
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 105
Totale 49.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020723 0 0 0 0 0 0 122 163 157 136 79 66
2020/2021909 39 113 55 80 25 87 46 89 126 61 95 93
2021/20221.132 35 124 138 87 29 77 48 124 42 36 130 262
2022/2023951 177 132 11 103 166 137 10 59 108 6 30 12
2023/2024326 22 57 36 32 18 30 8 22 6 2 47 46
2024/2025629 3 146 71 70 293 44 2 0 0 0 0 0
Totale 7.513